Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NAC-REPAIR: N-Acetylcysteine-facilitated Redox-Immune Modulation for Post-surgical Analgesia and Injury Recovery

NCT07227649 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT07227649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07227649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NAC-REPAIR: N-Acetylcysteine-facilitated Redox-Immune Modulation for Post-surgical Analgesia and Injury Recovery
Lead sponsor
University of Arizona
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
July 15, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carpal tunnel surgery, de quervain syndrome, dupuytren contracture, guyon's canal, morton neuroma, peroneal nerve entrapment, plantar fasciopathy, tarsal tunnel syndrome, trigger finger disorder